Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma

4 participants · First posted Aug 23, 2010

Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

60 participants · First posted Nov 4, 2007

Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

66 participants · First posted Jun 16, 2010

bispecific antibody (follicular lymphoma)

Idelalisib(Zydelig)

C₂₂H₁₈FN₇O · Rx

anti-CD22 degrader-antibody conjugates (non-Hodgkin lymphoma/NSCLC)

AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP

Australia

ASSOCIATION INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG)

Switzerland

The Cooper Health System, A New Jersey Non-Profit Corporation

United States

MAGEA4-Targeted Therapies Show Promise in Solid Tumors Beyond Synovial Sarcoma

California's $8.4 Billion Immunology Research Bond Heads to Voters Amid Federal Funding Crisis

FDA's Accelerated Approval Pathway Faces Scrutiny as Some Drugs are Withdrawn